Article Type
Changed
Thu, 12/15/2022 - 15:15
Display Headline
Anticancer Drug Aces Phase III Trial

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 21(2)
Publications
Topics
Page Number
13
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 21(2)
Issue
Federal Practitioner - 21(2)
Page Number
13
Page Number
13
Publications
Publications
Topics
Article Type
Display Headline
Anticancer Drug Aces Phase III Trial
Display Headline
Anticancer Drug Aces Phase III Trial
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Legacy Keywords
cancer, bortezomib, FDA, refractory multiple myelomacancer, bortezomib, FDA, refractory multiple myeloma
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media